Selçuk Atalay

Selçuk Atalay

Auto-generated profile, based on publicly available information

Selçuk Atalay

Private Practice in Perinatology, Ordu, Türkiye

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Journal of Medicine and Palliative Care
Verified
Journal Article
Open access
PDF file
FEFırat Ersan
Fırat Ersan
IBIşıl Turan Bakırcı
Işıl Turan Bakırcı
GŞGülsen Şener
Gülsen Şener
NÇNihal Çallıoğlu
Nihal Çallıoğlu
SASelçuk Atalay
Selçuk Atalay
GTGüray Tuna
Güray Tuna
Aims: To compare serum levels of sC5b-9, C3, C4, C1-INH, and CH50, which are indicators of complement system activation and regulatory processes, in pregnant women with and without fetal growth restriction (FGR). Methods: This study enrolled eighty-six women with gestational age between 24 and 36 weeks. Maternal blood samples were obtained from 43 patients diagnosed with FGR and 43 from healthy pregnancies. Serum complement levels were measured using commercially available ELISA kits according to the manufacturer’s instructions (SunRed, China). Results: When the levels of complement activation biomarkers of pregnancies with FGR were compared with those of healthy pregnancies, the C1est level was significantly higher, C4 and CH50 levels were slightly lower, and Sc5b9 and C3 levels were similar. Conclusion: While the exact role of complement activation in FGR remains fully elucidated, the elevated levels of C1-INH in women with FGR suggest a compensatory mechanism to mitigate thrombus formation and inflammation. This adaptive response may be a potential therapeutic target for improving placental function and pregnancy outcomes.

31 January 2025 in New Trends in Medicine Sciences
Verified
Journal Article
Open access
PDF file
VAVerda Alpay
Verda Alpay
SASelçuk Atalay
Selçuk Atalay
FEFırat Ersan
Fırat Ersan
IGIzel Günay
Izel Günay
Objective: The purpose of this study is to evaluate the prenatal sonographic features and postnatal outcomes in fetuses with ductus venosus agenesis (DVA) in a tertiary center. Material and Methods: We performed a retrospective study of 15 consecutive cases of DVA diagnosed in our perinatology department between January 2020 and October 2023. All clinic records, fetal echocardiograms, any accompanying anomalies, obstetrical ultrasounds, and postnatal echocardiograms were reviewed. Results: Of the 15 cases detected, umbilical vein had extrahepatic type connection in 8 fetuses (53.3%) and intrahepatic type connection in 7 fetuses (46.7%). 11 patients had associated anomalies including hydrops (n=3, 20%), cardiac (n=6, 40%), extracardiac structural (n=7, 46.7%) and chromosomal anomalies (n=3, 20%). In our patient group, only 4 cases (26.7%) presented with isolated DVA, of which 3 had intrahepatic type connection. Prenatal genetic testing including karyotype and microarray was performed in 8 patients (53.3%) and 3 (20%) of them had abnormal results. 4 women (26.7%) underwent legal termination of pregnancy. There were 2 (13.3%) neonatal deaths, and the remaining 9 cases (60%) were alive at last follow-up. Conclusion: DVA is associated with cardiac, extracardiac, and genetic anomalies independent of the site of umbilical venous connection. Postnatal outcomes in cases with DVA depend on the presence of additional anomalies. Fetuses with DVA and extrahepatic connection have additional risk for cardiac failure, hydrops and portal venous system agenesis which worsen the outcomes. DVA cases with intrahepatic connection associated with no or minor anomaly tend to have more favorable outcomes.

23 December 2024 in Journal of Medicine and Palliative Care
Verified
Journal Article
Closed access
NÇNihal Çallıoğlu
Nihal Çallıoğlu
IBIşıl Turan Bakırcı
Işıl Turan Bakırcı
FEFırat Ersan
Fırat Ersan
SASelçuk Atalay
Selçuk Atalay
GTGüray Tuna
Güray Tuna
Aims: To identify factors influencing the accuracy of estimated fetal weight in small for gestational age (SGA) fetuses. Methods: This retrospective cohort study included 268 women in the third trimester with singleton pregnancies and estimated fetal weight below the 10th percentile. Data were obtained from electronic medical records, and the Hadlock formula was used to estimate fetal weight through ultrasound measurements. Patients with fetal growth restriction due to placental insufficiency, preeclampsia, multiple pregnancies, or fetal anomalies were excluded from the study. The study groups were categorized based on differences between their estimated and actual birth weights. Results: The analysis showed that 24.3% of the cases had a difference of >10% between estimated and actual birth weights. The mode of delivery was significantly associated with weight difference, with a lower cesarean section rate in the group with a difference >10%. There were no significant differences in clinical and sonographic characteristics between the study groups. Perinatal outcomes did not exhibit significant differences in gestational age at delivery, delivery mode, sex, or meconium-stained amniotic fluid. However, there was a significant difference in birth weight, with higher birth weights observed in the group with a difference >10%. Logistic regression analysis did not reveal any statistically significant associations between the examined factors and weight differences >10%. Conclusion: This study highlights the challenges of accurately estimating fetal weight in SGA fetuses. Further research is needed to identify additional factors and develop more reliable methods for estimating fetal weight in these cases, aiming to improve prenatal management and reduce the risk of adverse outcomes.

28 April 2026 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
SASelçuk Atalay
Selçuk Atalay
MÇMelike Çaltekin
Melike Çaltekin
NÇNihal Çallıoğlu
Nihal Çallıoğlu
FEFırat Ersan
Fırat Ersan
VAVerda Alpay
Verda Alpay
IGIpek Emine Geyikoglu
Ipek Emine Geyikoglu
Objective: This study aimed to investigate the clinical utility of the delta neutrophil index (DNI) in distinguishing patients with intrahepatic cholestasis of pregnancy (ICP) from healthy pregnant women, and to assess its potential role in evaluating disease severity. Methods: This retrospective analysis included data from 249 pregnant women. Among them, 131 were identified with ICP, based on clinical symptoms and total bile acid levels ≥ 10 μ mol/L. The remaining 118 participants served as healthy controls. The ICP cases were categorized into mild (TBA 10–39 μ mol/L; n = 90) and severe (TBA ≥ 40 μ mol/L; n = 41) subgroups. Demographic data, routine blood parameters, and DNI values were evaluated across the groups. Results: The ICP group demonstrated significantly elevated white blood cell (WBC) counts, neutrophil counts, immature granulocyte (IG) levels, DNI values, and neutrophil-to-lymphocyte ratio (NLR) compared to controls (p < 0.05 for all). Both mild and severe ICP subgroups exhibited higher IG, DNI, and NLR than controls. Furthermore, DNI and IG values significantly differed between mild and severe ICP cases. Receiver operating characteristic (ROC) analysis revealed high diagnostic performance for both DNI (cut-off: 0.65; sensitivity: 82.4%; specificity: 78%) and IG (cut-off: 0.06; sensitivity: 77.1%; specificity: 82.2%). Conclusion: The DNI levels were markedly elevated in ICP and varied with disease severity, suggesting its potential as a noninvasive marker for both diagnosis and risk stratification.

29 September 2026 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
CDCagri Doǧan
Cagri Doǧan
SASelçuk Atalay
Selçuk Atalay
HTHakan Timur
Hakan Timur
Background: Most evidence on chromosomal microarray analysis (CMA) and exome sequencing (ES) in prenatal diagnosis comes from high-volume centres. We evaluated the incremental diagnostic contribution of additional testing modalities, non-invasive prenatal testing (NIPT) confirmation rates and pregnancy outcomes at a regional centre in Türkiye. Methods: Retrospective cohort of 120 consecutive amniocenteses (March 2022–June 2025). The pathway was retrospectively observed, not uniformly implemented: the intended first-tier panel (quantitative fluorescent PCR, G-banded chromosome analysis, CMA) was completed in 94 pregnancies (78.3%), CMA in 101 (84.2%); ES ( n = 13) and targeted testing ( n = 25) were selective. Findings were classified before analysis as fetal disease-causing or incidental/non-diagnostic. Cumulative yields use the whole cohort as denominator. Results: Abnormal findings occurred in 36 of 120 pregnancies (30.0%): 27 (22.5%) disease-causing and 9 (7.5%) incidental/non-diagnostic — 3 heterozygous pathogenic or likely pathogenic variants in autosomal recessive genes (2.5%) and 6 variants of uncertain significance (VUS; 5.0%). Disease-causing yield rose from 16.7% to 22.5%: seven of the 27 diagnoses were first identified by CMA, ES or targeted testing, a cohort-specific contribution, not a diagnostic yield, as these modalities were not applied uniformly. Abnormal ultrasonography was associated with an abnormal genetic finding (31/83 vs. 5/37; unadjusted OR 3.82, 95% CI 1.35–10.82); not significant for disease-causing findings alone. Within this referral stream, confirmation of 14 high-risk NIPT referrals was 6/6 for trisomies 21 and 18, 0/4 for sex chromosome and rare autosomal aneuploidies and 1/4 for copy-number variants; these should not be read as population-level positive predictive values. Outcome, sought only after an abnormal finding, was documented in 30 of 36; 22 were terminated (trisomy 18, 4/4; isolated VUS, 1/6). Conclusions: CMA, ES and targeted testing added diagnoses in a non-uniformly applied pathway (complete first-tier panel in 78.3%). The findings reinforce the importance of diagnostic confirmation of high-risk NIPT results before irreversible clinical decisions, particularly for less common targets, which were frequently not confirmed in this referral series. Termination frequencies varied across diagnostic categories; these descriptive differences should be considered in the context of the underlying fetal phenotype, diagnostic certainty, and parental preferences when counselling is provided.